Table 1.
Ratios of Percentage Distributions Between Gender Minority Individuals (GMI) and Combination of Males or Females (M&F) by Sociodemographics, Tumor Characteristics, Treatment Modality, and Survival Time, Cancers of Lung and Bronchus, California, 1986-2016
Characteristics | Categories | Ratio of Percentages (GMI : M&F) | 95% CIs | Fisher Exact Test P Value |
---|---|---|---|---|
Year of diagnosis | 1999 and earlier | 0.27 | (0.09-0.63) | |
2000-2010 | 1.09 | (0.66-1.71) | <.0001 | |
2011 and later | 2.30 | (1.42-3.52) | ||
Age at diagnosis, y | ≤40 | 0.00 | (0.00-8.71) | |
41-69 | 1.82 | (1.28-2.50) | <.0001 | |
70+ | 0.33 | (0.14-0.65) | ||
Race/ethnicity | Non-Hispanic white | 0.74 | (0.48-1.09) | <.0001 |
Non-Hispanic black | 2.39 | (1.03-4.70) | ||
Hispanic | 1.77 | (0.71-3.64) | ||
API+AIAN+Other | 1.26 | (0.41-2.94) | ||
Socioeconomic status | Low SES | 1.24 | (0.77-1.90) | .009 |
Middle SES | 0.90 | (0.41-1.71) | ||
High SES | 0.83 | (0.47-1.37) | ||
Histologic subtype | Adenocarcinoma | 0.96 | (0.55-1.57) | .002 |
Squamous cell | 0.84 | (0.34-1.72) | ||
Other | 0.91 | (0.42-1.72) | ||
Unknown | 1.28 | (0.68-2.19) | ||
Tumor stage at diagnosis | In situ | 0.00 | (0.00-75.05) | <.0001 |
Stage I | 0.70 | (0.23-1.63) | ||
Stage II/III | 1.15 | (0.59-2.01) | ||
Stage IV | 1.45 | (0.92-2.18) | ||
Unknown/unavailable | 0.43 | (0.14-1.01) | ||
Surgical treatment | Yes | 1.04 | (0.50-1.90) | .1407 |
No/Unknown | 0.99 | (0.69-1.38) | ||
Chemotherapy | Yes | 1.09 | (0.62-1.77) | .1131 |
No/unknown | 0.96 | (0.64-1.37) | ||
Radiation | Yes | 0.95 | (0.53-1.57) | .1219 |
No/unknown | 1.03 | (0.69-1.46) | ||
Survival time | ≤12 mo | 1.00 | (0.66-1.44) | .1167 |
12+ mo | 1.01 | (0.59-1.61) |
AIAN = American Indian and Alaska Native; API = Asian and Pacific Islander; SES = socioeconomic status.